CIMPLE Explorer
  • Reviews
0 search results
English
http://fullfact.org/health/lung-cancer-drug-brexit/(permalink)
Author: full-fact
Factors
veracity
not verifiable
language
English
Date published
2021-05-11
Entities
OsimertinibDaily ExpressEuropean CommissionMatt HancockMutationEuropean Medicines AgencySwitzerlandSingaporeBrexitSocial mediaCanadaAustraliaCancerEuropean UnionUnited KingdomBrazilFull FactSmall-cell carcinomaOrbis InternationalSubgroupNon-small-cell lung carcinoma

Claims (1)

  • A new lung cancer drug has been authorised under an international scheme that the UK has been able to join post Brexit.

The data contained in CIMPLE Explorer comes from CIMPLE Knowledge Base. CIMPLE Explorer has been developed at EURECOM.

CIMPLE Explorer
English
ReviewsClaim-review